Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shashen Maidong Granules is a Traditional Chinese Medicine (TCM) product developed for the treatment of respiratory conditions such as chronic cough and cough variant asthma. The formulation is based on the classic Sha Shen Mai Dong Tang decoction, which traditionally includes *Radix Glehniae*, *Radix Ophiopogonis*, *Polygonatum odoratum*, and other herbs known for their Yin-nourishing and heat-clearing properties. Developed by Hubei Liyi Pharmaceutical Technology Co., Ltd., these granules are designed to moisten the lungs and alleviate dry throat and persistent coughing. In modern clinical practice, it is often used as an adjunctive or primary therapy for patients exhibiting Yin deficiency patterns in chronic respiratory diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shashen maidong granules.